Skip to main content
Figure 2 | BMC Pharmacology and Toxicology

Figure 2

From: Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy

Figure 2

Rifabutin median concentration-time profiles. Median rifabutin (RBT) concentrations for the three pharmacokinetic evaluations in 14 patients. The orange line corresponds to the dosing of RBT at 300 mg without ART; the blue line to RBT dosing at 150 mg tiw with ART and the purple line to dosing with 150 mg of RBT daily with ART. The bars represent interquartile range (IQR).

Back to article page